| Hans-Günter Meyer-Thompson | Kokain
Oxytocin protocol appears workable and safe for methadone patients who use cocaine
Oxytocin protocol appears workable and safe for methadone patients who use cocaine
Some 30 to 60 percent of patients in methadone maintenance therapy (MMT) for opioid use disorders use cocaine. Compared to other MMT patients, those who use cocaine have higher rates of relapse and mortality. Studies with animals have suggested that the hormone oxytocin could be doubly helpful to these patients, by reducing the addictive effects of both opioids and cocaine. Now, researchers supported by the National Institute on Drug Abuse have developed a protocol for adjunctive oxytocin treatment, and a pilot study has indicated that it is workable and safe for MMT patients. (NIDA, Science Highlight, 09.01.2018)